Jaguar Gene Therapy
Accelerating breakthroughs in gene therapy.
- Business Model
- B2B
- Website
- jaguargenetherapy.com
- Total Funding
- $179.0M
- Last Round
- $139.0M Series BApr 2021
- Rounds
- 2
About
Biotechnology company accelerating breakthroughs in gene therapy for patients with severe genetic diseases.
Summary
Jaguar Gene Therapy is a Biotech company. It has raised $179.0M in total across 2 rounds, most recently a $139.0M Series B round in Apr 2021. Investors include Deerfield Management, Eli Lilly and ARCH Venture Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Apr 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company